Periodontal Therapeutic Market is Growing at a Promising CAGR of 9.2% During Forecast to 2023


Market Overview:
Periodontal continues to be one of the major causes of tooth loss and a major oral health issue. The disease is common in both developed and developing countries, affecting nearly 20 to 50% of the global population. Over the years, different periodontal therapies have come up with a high degree of effectivity. Both surgical and non-surgical treatment options available.
Global Periodontal Therapeutic Market Insights set to witness a strong growth in the forthcoming years. The latest study conducted by Market Research Future (MRFR) reveals that the global periodontal therapeutic market will surge at 9.2% CAGR during 2018 to 2023. 
The onset of periodontal issues could be triggered by poor oral hygiene, diabetes mellitus, stress, smoking and hormonal changes in females. The incidence rate has continued to grow, which is also driving the demand for periodontal therapeutic. As per World Health Organization (WHO), there is a high incident rate of gingival bleeding in adults worldwide.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6562

Meanwhile, 10 to 15% of adults are affected with deep periodontal pockets (6 mm or more) globally. Major drivers of the global periodontal therapeutic market include rising geriatric population and growing worldwide healthcare spending. Nevertheless, poor level of awareness and negligence towards oral hygiene, especially in third-world countries are among the key bottlenecks for the market.
Competitive Landscape 
·         Tolmar Inc
·         Align Technology Inc
·         3M-ESPE
·         Nobel Biocare Holdings AG
·         Orapharm
·         Valeant Pharmaceuticals Int
·         Mallinckrodt Pharmaceuticals
·         Teva Pharmaceutical Industries Limited
·         Ultradent Products Inc
·         Eli Lilly & Company
·         Glidewell Laboratories
·         Den-Mat Holdings

Segmental Overview
·         The segmental analysis on the global periodontal therapeutic market is based on treatment, type and end-users.
·         By treatment, the market has bees segmented into local antibiotics and systematic antibiotics.
·         Based on type, the market has been segmented into aggressive periodontitis, chronic periodontitis, gingivitis and necrotizing periodontal disease.
·         By end-user, the market has been segmented into hospitals and dental clinics

Global Periodontal Therapeutic Market: Regional Segmentation
A booming need for more oral hygiene appeal in the field of periodontal treatment is being observed worldwide. The rising awareness regarding oral hygiene and increasing incidence of the periodontal disorder among people are factors responsible for the growth of the market in this region.
The market in the Americas is expected to boost the global periodontal therapeutic market owing to technological advancement and increasing incidences of the periodontal disorder among diabetic patients. According to recent findings from the Centers for Disease Control and Prevention (CDC), half of Americans aged 30 or older have periodontitis, the more advanced form of periodontal disease. This equals approximately 64.7 million Americans. This is largely attributed to the accessibility of an urban healthcare infrastructure. The European market is expected to be the second-largest due to government funding and support from the healthcare sector coupled with the rising prevalence of the periodontal disorder. However, Asia-Pacific is projected to dominate in terms of growth rate over the forecast period owing to rising investment towards R&D activities and unhealthy lifestyle which are resulting in an increased prevalence of obesity. Rising geriatric population and the increasing prevalence of diabetes in this region have a positive influence on the development of the periodontal therapeutic market in this region.  The Middle East and Africa account for the smallest share due to lack of medical technology and poor medical facilities. Emerging economies such as India and China are leading to growth in demand for periodontal therapeutic owing to increasing number of healthcare awareness programs, government investment in healthcare and favorable healthcare insurance coverage. National Oral Health Programmed (NOHP) was conceptualized by the Indian Dental Association to ensure optimal oral health for all by increasing awareness, assuring excellent service and high-quality dental care




Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more